Back story here.
Schering-Plough and Merck are being investigated by U.S. lawmakers on allegations that the drugmakers are withholding data from a study that may change how doctors treat high cholesterol.
In a letter dated Dec. 11 and emailed to journalists, Rep. John Dingell, Chairman of the Committee on Energy and Commerce, and Rep. Bart Stupak, Chairman of the Oversight and Investigations Subcommittee, requested information on the delayed release of data from their ENHANCE trial concluded in April 2006.
Source
No comments:
Post a Comment